BTIG Keeps Their Buy Rating on Xtant Medical Holdings (XTNT)
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Xtant Medical Holdings (XTNT – Research Report), with a ...
BTIG Keeps Their Buy Rating on RxSight (RXST)
In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on RxSight (RXST – Research Report), with a price target of ...
GE Healthcare raised to Buy at BTIG on potential H2 beat
during a meeting with BTIG, indicated that the company has already added 75% of what is required to hit H2 2024 numbers to ...